濮阳东方医院收费透明濮阳东方医院男科割包皮非常好,濮阳东方男科医院评价高,濮阳东方男科医院割包皮手术好吗,濮阳东方医院男科割包皮比较好,濮阳东方医院妇科做人流手术评价,濮阳东方医院看阳痿收费公开,濮阳东方医院看男科非常的专业

BEIJING, March 14 (Xinhuanet) – "Angry Birds" game developers at Rovio have announced a funding of 42 million U.S. dollars to expand their "mean pigs, cranky birds" empire, according to foreign media report Sunday.The funding, announced Thursday, is the first venture-capital money Rovio has secured. Richard Wong with Accel Partners, who led the firm's investment in Rovio, hailed "Angry Birds" as "an incredible consumer franchise beyond just being a mobile game."With the newly raised funding, "Angry Birds" developers have made a strategic plan to achieve the brand growth of "Angry Birds."According to developer Peter "Mighty Eagle" Vesterbacka, Rovio is going to expand the franchise of "Angry Birds" in a lot of directions such as movie, broadcast and TV."We are working on a game that will involve Facebook ... really the plan is to make "Angry Birds" playable everywhere," said Vesterbacka. Besides its efforts in digital realm, Rivio is also exploring the potential toy market. Ravio has already sold over two million "Angry Birds" plush toys, which have broken into the mainstream retail channels. Recently Ravio has also branched out into selling "Angry Bird" apparel."Angry Birds", hatched in 2009, has dominated Apple's list of top-selling iPhone apps since it took flight last year. It is now available on many other platforms -- iPad, Android, iTouch, and almost every other smartphone out there.The game became world-polupar as it is easy to pick up and very addictive. Rovio, a mobile game development studio founded in Finland in 2003, enjoys the reputation as one of the most innovative game shops in Europe.

BEIJING, Feb. 18 (Xinhua) -- In the next five years, China will further expand the coverage of its basic medical insurance system and ease the cost of medical services, Health Minister Chen Zhu said Friday.Chen made the remarks while addressing a meeting for the reform of the health care system.The medical expenditure that shouldered by individuals had been cut to 38.2 percent of China's annual overall spending on medical services in 2009, down from 60 percent in 2001, thanks to increasing government funding support for the measure, said Chen.He said the country is striving to bring down the ratio to below 30 percent by the end of the country's 12th five-year plan period (2011-2015).China is steadily pushing towards the implementation of a basic medicine system which aims to ensure affordable access to essential drugs for patients, Chen said.In the areas already covered by basic medicine system, the average price of basic medicine has dropped by around 30 percent, Chen added.He said that the reform of government-run hospitals, which is key to ensure that the masses gain universal access to basic health care services, must be undertaken.In 2011, more measures will be made to restructure the distribution of public hospitals, reform government-run traditional Chinese medical institutions and support building and developing hospitals in county-level regions, Chen said.

WASHINGTON, April 11 (Xinhua) -- Taking a statin before having major elective surgery reduces potentially serious kidney complications, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.Each year, more than 230 million major elective surgeries are performed around the world. Unfortunately, many patients who undergo major operations develop kidney injury soon after surgery, often due to decreased blood flow to the kidneys and/or the effects of inflammation.Animal studies suggest that the cholesterol-lowering drugs called statins protect the kidneys from such damage, but whether a similar benefit occurs in humans is uncertain. To investigate, Amber Molnar, University of Western Ontario, and colleagues conducted a population-based retrospective study of all older patients who underwent major elective surgery in the province of Ontario, Canada from 1995 to 2008. Surgeries included cardiac, thoracic, vascular, intra-abdominal, and retroperitoneal procedures.A total of 213,347 patients from 211 hospitals underwent major elective surgery, and 4,020 patients (1.9 percent) developed postoperative kidney injury within two weeks of surgery. A total of 1,173 patients (0.5 percent) required dialysis within two weeks of surgery, and 5,974 patients (2.8 percent) died within a month of surgery.Prior to surgery, 67,941 patients (32 percent) were taking a statin. Patients taking a statin were 20 percent less likely to develop kidney injury, need dialysis, and die compared to patients who were not taking a statin. Also, there was evidence of a dose-effect, with patients on higher potency statins having less kidney injury. In addition, statins were beneficial whether they were started greater than 90 days or less than 30 days prior to surgery."Our study suggests that statin use in older persons results in less kidney injury following major elective surgery and reduces the risk of premature death after surgery," said Molnar, adding that the results warrant further investigation with more rigorous studies, but such trials will be difficult to carry out.

RIO DE JANEIRO, March 25 (Xinhua) -- The number of dengue fever cases in Rio de Janeiro city this year has already surpassed 10,000, local health authorities said on Friday.According to the city's Health Secretariat, in less than three months, the number of confirmed dengue fever cases in Rio reached 10,158, exceeding the figures registered in the entire years of 2009 (2,723) and 2010 (3,120).In Rio de Janeiro state, the number of confirmed dengue fever cases reached 20,150, and the death toll rose to 18.This week, the first two cases of type-4 dengue fever in Rio de Janeiro state were confirmed in the city of Niteroi. The type-4 dengue fever is not more dangerous than the other types, but as the disease had not been registered in the region before, the local population has no immunity to it.As there are four different types of dengue fever, a person can develop the disease several times.The last epidemic of dengue fever in Rio de Janeiro state occurred in 2008 when 174 people died of the disease and some 250,000 cases of dengue were registered.

BEIJING, Feb. 18 (Xinhua) -- China needs to reform funding methods for scientific and technological research in order to boost the nation's innovation capabilities, said officials and researchers attending a conference in Beijing Friday.The management of the government-funded research projects should also be reformed, State Councilor Liu Yandong said at the national conference on science and technology work.Liu stressed that reform, innovation and cooperation should be the keys for China's science and technology work over the next five years, when the government would increase funding for research in new strategic industries, such as new energy, biomedicine and high-end manufacturing.Last year, central and local government spending on science and technology development totaled 380 billion yuan (57.8 billion U.S. dollars), Science and Technology Minister Wan Gang said at the conference.Over the past five years, central government spending on science and technology development had grown by around 20 percent annually.However, some researchers have complained problems in the funding system actually hinder innovation and progress.Inflexibility in the management of government funds allowed researchers little freedom to adapt projects to developments in their fields, said Li Zhenzhen, a researcher at the Institute of Policy and Management under the Chinese Academy of Sciences (CAS).Chen Jie, a research fellow of the CAS' Institute of Microelectronics, said some authorities which oversee the spending of research funds had been rather rigid."In some cases, they are more interested in spending most of the funds on new equipment than scientists," Chen said in an earlier interview with Xinhua. "Without decent pay, it is difficult to attract top scientists to work in China.""Having to solicit and lobby for funding to support the team's research projects leaves me no more than five hours a day for real research," Chen said.Top-level scientific brains are the key to the innovative capability of China, he added.A researcher attending Friday's conference echoed Chen's opinion."China manufactures 65 percent of the world's computers. But to my knowledge, we are still spending about 150 billion U.S. dollars annually to buy computer chips from overseas," the researcher told Xinhua on condition of anonymity.Wan Gang also said imported computer chips cost China more than crude oil purchases last year.But Wan believed that with breakthroughs in frontier areas such as cloning, manned space flight, moon exploration and supercomputers, China could expect a leap in science and technology development in the near future.In October last year, China successfully launched its second lunar probe, Chang'e-2.A month later, Chinese supercomputer Tianhe-1A, which can perform 2.57 quadrillion computing operations a second, was ranked the world's fastest in the TOP500 list compiled by U.S. and European researchers.